BeOne Medicines (ONC)

BeOne Medicines (ONC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ONC last traded at $361.47, -2.39% on the day.
• BeOne Medicines: P/E 25.1, revenue $6.13B over the last four quarters.
• Over the past year ONC returned 17.28%; year to date 18.98%.

Updated 2026-11-02 21:37 UTC